Gilead Sciences Earnings Preview: What to Expect

Gilead Sciences Earnings Preview: What to Expect

Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company based in Foster City, California, known for discovering, developing and commercializing innovative medicines that address serious unmet medical needs in areas such as HIV/AIDS, viral hepatitis, COVID-19, oncology and inflammation. Gilead Sciences has a market capitalization of around $155 billion, reflecting its position as a major…

Read More
Scotiabank analyst sees opportunity in large-cap biopharma sector and maintains GILD outperformance

Scotiabank analyst sees opportunity in large-cap biopharma sector and maintains GILD outperformance

Gilead Sciences, Inc. (NASDAQ:GILD) is included among the The 15 Best Passive Income Stocks to Buy Right Now. Scotiabank analyst sees opportunity in large-cap biopharma sector and maintains GILD outperformance On November 12, Scotiabank analyst Louise Chen began covering ten large-cap biopharma companies and shared a “non-consensus” positive view on the sector, according to a…

Read More